EZN-2285 or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

This study is currently recruiting participants.

Study NCT00671034 Information provided by National Cancer Institute (NCI)

First Received: May 1, 2008 Last Updated: November 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2018 (Final data collection date for primary outcome measure)